Susceptibility Profile of Nitrofurantoin and Fosfomycin among Carbapenem-resistant Enterobacteriaceae Isolates in UTI from a Tertiary Care Hospital

UTI is one of the most common infections requiring antibiotic treatment and hospitalization. The rising trend in multidrug resistance to commonly used antibiotics has reduced the therapeutic options for treating these infections. Reexploring older antibiotics like nitrofurantoin and fosfomycin provi...

Full description

Bibliographic Details
Main Authors:	Januki Kalai, D. Maheswary, K.V. Leela, Anusha Gopinathan
Format:	Article
Language:	English
Published:	Journal of Pure and Applied Microbiology 2023-03-01
Series:	Journal of Pure and Applied Microbiology
Subjects:	uti carbapenem resistance mic nitrofurantoin fosfomycin enterobacteriaceae
Online Access:	https://microbiologyjournal.org/susceptibility-profile-of-nitrofurantoin-and-fosfomycin-among-carbapenem-resistant-enterobacteriaceae-isolates-in-uti-from-a-tertiary-care-hospital/

Similar Items

In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae
by: Ausilia Aprile, et al.
Published: (2020-12-01)

Fosfomycin Versus Nitrofurantoin Efficacy Against Multi-Drug Resistant Gram Negative Urinary Pathogens.
by: Shah M, et al.
Published: (2018-01-01)

Efficacy of Five Days Nitrofurantoin Therapy versus Fosfomycin Stat Dose in Clinical Resolution of Uncomplicated Urinary Tract Infections
by: Hasham Bin Tahir, et al.
Published: (2023-02-01)

In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections
by: Gopichand P, et al.
Published: (2019-07-01)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
by: Asher Shafrir, et al.
Published: (2023-03-01)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
by: Antonio Sorlozano-Puerto, et al.
Published: (2020-08-01)

Treatment of Non - Complicated Lower Urinary Tract Infection in Pregnancy: Single Dose Fosfomycin Tromethamine Versus Multiple Dose Nitrofurantoin
by: Murat Özel, et al.
Published: (2011-04-01)

In vitro Susceptibility Analysis of Escherichia coli Strains Isolated from Urinary Tract Infections to Fosfomycin, Nitrofurantoin and Ciprofloxacin
by: Sevda SOYDAN, et al.
Published: (2015-12-01)

Nitrofurantoin-induced acute respiratory distress syndrome during pregnancy: A case report
by: Sherif S. Wahba
Published: (2014-01-01)

Analysis of nitrofurantoin sensitivity in multi drug resistant gram negative bacilli causing UTI in a teaching hospital – A cost effective option
by: T Sabarinathan, et al.
Published: (2024-02-01)

Analysis of nitrofurantoin sensitivity in multi drug resistant gram negative bacilli causing UTI in a teaching hospital – A cost effective option
by: T Sabarinathan, et al.
Published: (2024-02-01)

Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis
by: Wasan Katip, et al.
Published: (2024-05-01)

Transporter Genes and fosA Associated With Fosfomycin Resistance in Carbapenem-Resistant Klebsiella pneumoniae
by: Yu-Ping Wang, et al.
Published: (2022-01-01)

Fosfomycin Susceptibility among Extended-spectrum βeta Lactamase (Esbl)-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Uti in a Tertiary Care Center in Western India
by: Shrutika R. Kumbhar, et al.
Published: (2024-04-01)

The efficacy of fosfomycin trometamol in prevention of postoperative urinary tract infection in pregnant women after endoscopic procedures: open clinical trial
by: Mohamed Radwan, et al.
Published: (2021-12-01)

Evaluation of in vitro effect of Fosfomycin on resistant Gram-negative pathogens in urinary tract infection
by: Zeinab Ibrahim, et al.
Published: (2022-05-01)

Daily fosfomycin versus levofloxacin for complicated urinary tract infections
by: Nadine Rouphael, et al.
Published: (2023-10-01)

Fosfomycin: Still a Competent Treatment Option in Urinary Tract Infections
by: Paul Grama, et al.
Published: (2020-07-01)

Fosfomycin, a therapeutic option for infections produced by multiple drug-resistant Enterobacteriaceae
by: Fatemeh Yeganeh Sefidan, et al.
Published: (2016-07-01)

Fosfomycin, Applying Known Methods and Remedies to A New Era
by: Viviana Albán M., et al.
Published: (2020-08-01)

Near-Infrared Spectroscopy Evaluations for the Differentiation of Carbapenem-Resistant from Susceptible Enterobacteriaceae Strains
by: Bushra Alharbi, et al.
Published: (2020-09-01)

Carbapenem Resistant Enterobacteriaceae in Africa
by: Bashar Haruna Gulumbe, et al.
Published: (2020-05-01)

Assessing the urinary concentration of nitrofurantoin and its antibacterial activity against Escherichia coli, Staphylococcus pseudintermedius, and Enterococcus faecium isolated from dogs with urinary tract infections
by: Chien-Che Hung, et al.
Published: (2023-07-01)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
by: Matthew E. Falagas, et al.
Published: (2014-07-01)

Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
by: Peng Liu, et al.
Published: (2020-09-01)

Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant enterobacteriaceae and carbapenemase-producing enterobacteriaceae
by: Marimuthu, Kalisvar, et al.
Published: (2020)

Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains
by: Fatemeh Yeganeh-Sefidan, et al.
Published: (2016-05-01)

Molecular mechanisms of carbapenem resistance among Enterobacteriaceae isolated at Teaching Hospital, Batticaloa
by: M. S. Shihana, et al.
Published: (2021-04-01)

Clinical Laboratory Aspect of Carbapenem-Resistant Enterobacteriaceae
by: Chang-Eun Park
Published: (2020-03-01)

30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study
by: Marya D. Zilberberg, et al.
Published: (2017-12-01)

Carbapenem-Resistant Enterobacteriaceae among In-Patients of Tertiary Hospitals in Southwest, Nigeria
by: Ibikunle I. ANIBIJUWON, et al.
Published: (2018-09-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

Inactivation of ackA and pta Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in Escherichia coli
by: Hidetada Hirakawa, et al.
Published: (2023-06-01)

Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China
by: Haichen Wang, et al.
Published: (2021-04-01)

Evaluation of automated systems for aminoglycosides and fluoroquinolones susceptibility testing for Carbapenem-resistant Enterobacteriaceae
by: Zhichang Zhao, et al.
Published: (2017-08-01)

Comparative Evaluation of Seven Tigecycline Susceptibility Testing Methods for Carbapenem-Resistant Enterobacteriaceae
by: Li H, et al.
Published: (2021-04-01)

Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
by: Chau-Chyun Sheu, et al.
Published: (2019-01-01)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
by: Yamuna Devi Bakthavatchalam, et al.
Published: (2020-04-01)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
by: Priyam Batra, et al.
Published: (2020-01-01)

Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for Klebsiella pneumoniae
by: Morgan L. Bixby, et al.
Published: (2024-08-01)